Filing Details

Accession Number:
0001567619-20-013185
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-10 18:53:21
Reporting Period:
2020-07-10
Accepted Time:
2020-07-10 18:53:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882361 Aptose Biosciences Inc. APTO Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1777513 Jotin Marango C/O Aptose Biosciences Inc.
251 Consumers Road, Suite 1105
Toronto A6 M2J 4R3
Senior Vp, Chief Bus. Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2020-07-10 62,835 $6.05 116,219 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares automatically sold by the reporting person to satisfy tax withholding obligations in connection with the vesting of 120,000 restricted stock units, previously reported on a Form 4/A filed with Securities and Commission on March 10, 2020.